Stock:
Symbol Lookup
Register | Login
...
History
...
...

Pre Market | Dow Jones | Gold | Newsletters | Learn


Sequenom - SQNM - 2012 was a year of remarkable progress for Sequenom

Monday, January 7, 2013 11:17 AM
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, announced preliminary highlights of the Company's 2012 performance and accomplishments. SQNM - Initial 2012 Performance Results (unaudited)
  • Total revenue of approximately $89 million, growth of approximately 59 percent year-over-year for 2012
  • Diagnostic services revenues of approximately $46 million, compared to $8.3 million in 2011.  Diagnostic services revenues continue to be recorded primarily as cash is received
  • Sales in the Genetic Analysis business of approximately $43 million
  • More than 92,000 total prenatal and retinal diagnostic tests accessioned during the year
  • Strong increases in the adoption rate and sales of Sequenom Center for Molecular Medicine's (Sequenom CMM) MaterniT21 PLUS lab-developed test (LDT):
    • More than 60,000 MaterniT21 PLUS tests accessioned in 2012
    • An annualized run rate of more than 120,000 MaterniT21 PLUS tests accessioned at the end of 2012
    • Approximately 56 million lives under coverage with growing number of payor contracts
    • Continued reimbursement as an out-of-network laboratory from large commercial payors
  • Total cash, cash equivalents, and marketable securities as of December 31, 2012 were approximately $176 million
  • Cash burn of approximately $17 million for the fourth quarter of 2012
"2012 was a year of remarkable progress for Sequenom.  The rapid adoption of the Sequenom CMM's MaterniT21 PLUS by the OB/GYN physician community far exceeded the Company's internal goal and the estimates of industry analysts.  The joint recommendation by the American College of Obstetricians and Gynecologists (ACOG) and the Society of Maternal and Fetal Medicine (SMFM) for the use of noninvasive prenatal tests (NIPT) such as the MaterniT21 PLUS in high risk pregnancies provided an additional validation for this technology.  The company also exceeded the majority of its other goals as it established Sequenom CMM as a leader in the prenatal testing market," said Harry F. Hixson, Jr, Ph.D., Chairman and CEO of Sequenom.  "We look forward to the continued growth of the MaterniT21 PLUS LDT in 2013 and the corresponding increase in test capacity.  We plan to work with national and regional payors to establish additional contracts facilitating the availability of the MaterniT21 PLUS LDT to high-risk pregnant women throughout the United States." About Sequenom - SQNM Sequenom, Inc. (SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. SQNM was founded in 1994 and is headquartered in San Diego, California.
PRINT

FREE Options Trading Lessons
I'll show you how to unlock HUGE Gains with Options Trading
Let's make 2014 the year you get RICH!

Latest Headlines

Must Watch Stocks for TodayMust Watch Stocks for Today
Some of the stocks that may grab investor focus today are: Macy`s (NYSE: M ) will be in focus on Black Friday. China will see its first Black Friday sales this year as US retailers like Macy`s offe...
EU plans to streamline but not change key budget rulesEU plans to streamline but not change key budget rules
BRUSSELS (Reuters) - The European Commission wants to streamline the European Union`s complex rules governing economic policy-making, but won`t change the two key laws that sharpened budget policy c...
Russian economy minister says will cut 2015 oil price forecastRussian economy minister says will cut 2015 oil price forecast
MOSCOW (Reuters) - Russian Economy Minister Alexei Ulyukayev said on Friday the government would its cut oil price forecast for 2015, but declined to give a number. The oil price has slumped from ne...
ECB's Nouy says banks must show they can make profitsECB's Nouy says banks must show they can make profits
LONDON (Reuters) - Euro zone banks that failed or barely passed this year`s health checks will have to demonstrate they can make sustainable profits and may need to sell off loss-making units, the E...
ECB's Nouy says banks must show they can make profitsECB's Nouy says banks must show they can make profits
LONDON (Reuters) - Euro zone banks that failed or barely passed this year`s health checks will have to demonstrate they can make sustainable profits and may even need to sell off loss-making units, th...

Loading Headlines...
 

Stock Market

Track the stock market today with the latest news and information on all things investing! Watch your stocks perform throughout the day and watch the breaking stock market news.

Feedback | disclaimer | privacy policy

Stock Market News

The Stock Market is ever changing. Keep up on your stock market news.

Stock Market Newsletters

Read up on your favorite stock market newsletters.


Learn the Stock Market

Sharper your stock trading skills with our stock market education section.

Algorithm Based
Trade Signals
arrow
small cap swing trades SmallCaps stocks under $10
Index Signals Index Signals SPY, QQQ, DIA, IWM
options trading Mega Stocks options + stock trade signals
Forex Forex Signals major FX pairs signals